» Articles » PMID: 38064172

Impact of Obese Patients in Ovarian Cancer Surgery on Postoperative Wound Complications: A Meta-analysis

Overview
Journal Int Wound J
Date 2023 Dec 8
PMID 38064172
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of obesity on wound-related outcomes in post-ovarian cancer patients is not clear. A number of studies on the association of fat with post-operation injury in ovarian carcinoma have produced contradictory findings. This study aims to conduct a study of the available data to assess the association of obese individuals with significant surgery results in ovarian cancer. We looked up Cochrane Library, Embase, and PubMed for qualifying research on ovarian cancer operations to determine the primary evidence for evaluating the association of obesity with post-surgical wound injury in ovarian cancer. The odds ratio (OR) was analysed with a fixed effect model if the variability of the study was small; otherwise, the analysis of the data was done with a random effect model. Out of 1259 related trials which were reviewed for eligibility, 6 publications were chosen from 2009 to 2019, 3076 patients who had had an operation for ovarian cancer. Obesity has been linked to an increased rate of wound-related complications in ovarian cancer operations compared to those without obesity (OR, 0.50; 95% CI, 0.37, 0.69 p < 0.0001). Non-obesity was significantly less likely to occur with respect to operation time compared to those with obesity (MD, -48.00; 95% CI, -55.33, -40.68 p < 0.00001). There were no statistically significant differences in the rate of haemorrhage after the operation (OR, 0.26; 95% CI, 0.04, 1.57, p = 0.14). Because of the limited number of trials in this meta-analysis, caution should be exercised in their treatment. More high-quality research with a large sample is required in order to confirm the findings.

Citing Articles

Impact of obese patients in ovarian cancer surgery on postoperative wound complications: A meta-analysis.

Huang X, Du S, Wang Q, Yang C, Liu X, Chen K Int Wound J. 2023; 21(4):e14439.

PMID: 38064172 PMC: 10957721. DOI: 10.1111/iwj.14439.

References
1.
Fotopoulou C, Richter R, Braicu E, Kuhberg M, Feldheiser A, Schefold J . Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking. Ann Surg Oncol. 2011; 18(9):2629-37. DOI: 10.1245/s10434-011-1637-z. View

2.
Torre L, Trabert B, DeSantis C, Miller K, Samimi G, Runowicz C . Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018; 68(4):284-296. PMC: 6621554. DOI: 10.3322/caac.21456. View

3.
Castro B, Dos Reis R, Fontes Cintra G, Sousa M, Vieira M, Andrade C . Predictive Factors for Surgical Morbidities and Adjuvant Chemotherapy Delay for Advanced Ovarian Cancer Patients Treated by Primary Debulking Surgery or Interval Debulking Surgery. Int J Gynecol Cancer. 2018; 28(8):1520-1528. DOI: 10.1097/IGC.0000000000001325. View

4.
Wright J, Tian C, Mutch D, Herzog T, Nagao S, Fujiwara K . Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2008; 109(3):353-8. DOI: 10.1016/j.ygyno.2008.02.023. View

5.
Winfield R, Reese S, Bochicchio K, Mazuski J, Bochicchio G . Obesity and the Risk for Surgical Site Infection in Abdominal Surgery. Am Surg. 2016; 82(4):331-6. View